Our findings did not show sufficient evidence on the association of genetically proxied inhibition of PCSK9 or NPC1L1 as well as genetically determined LDL cholesterol levels with the risk of ankylosing spondylitis. Here, NPC1L1 is linked to ankylosing spondylitis.